Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(24 sites)
United States
Phoenix Children's Hospital/Dignity Health, Phoenix, Arizona University of California - Los Angeles (UCLA), Los Angeles, California Stanford University, Palo Alto, California University of California-San Francisco, San Francisco, California University of Colorado, Denver (UCD), Aurora, Colorado Yale University School of Medicine, New Haven, Connecticut Children's National Medical Center/George Washington University, Washington D.C., District of Columbia University of Kentucky / Kentucky Children's Hospital, Lexington, Kentucky University of Louisville / Norton Children's Hospital, Louisville, Kentucky University of Michigan / C. S. Mott Children's Hospital, Ann Arbor, Michigan Children's Hospital of Minnesota, Minneapolis, Minnesota Perinatal Associates of New Mexico, Rio Rancho, New Mexico NYU Langone Health, New York, New York Mount Sinai, New York, New York Columbia University Medical Center, New York, New York UH Rainbow Babies / Children's Hospital, Cleveland, Ohio Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio Vanderbilt University Medical Center, Nashville, Tennessee Baylor College of Medicine, Houston, Texas University of Utah Health, Salt Lake City, Utah University of Vermont Children's Hospital, Burlington, Vermont Eastern Virginia Medical School (EVMS), Norfolk, Virginia Seattle Children's Hospital, Seattle, Washington Canada
Stollery Children's Hospital, Edmonton, Alberta